New Publication about gut microbiota & diabetes patients – in collaboration with Genetic Analysis

Exploring the gut microbiota in patients

BIOASTER is glad to share the last scientific article published in BMC Endocrine Disorders in August 2023 in collaboration with the team of Genetic Analysis ( The aim of this study was to explore the gut microbiota and bacteria associated with prediabetes patients, and treatment naive type 2 diabetes patients, compared to healthy subjects. A new demonstration that LUMI-Seq™, the full-length 16S (V1-V9) Illumina sequencing technology developed by BIOASTER is helpful to highlight new gut microbiome biomarkers of medical added value.

See the article: HERE